Showing results (211-220 of 9,974) with videos related to

Sort By:
Pageof 998
Leukemia & Lymphoma|April 15, 2003
HIV-testing and newly-diagnosed malignant lymphomas. The SAKK 96/90 registration studyGiannicola D'Addario, Alexander Dieterle, Joachim Torhorst, et al.
Leukemia & Lymphoma|April 15, 2003
In AML cell lines Ara-C combined with purine analogues is able to exert synergistic as well as antagonistic effects on proliferation, apoptosis and disruption of mitochondrial membrane potentialKai U Chow, Simone Boehrer, Simone Napieralski, et al.
Leukemia & Lymphoma|April 15, 2003
A type of rat hepatosplenic gamma-delta (gammadalta) T-cell lymphoma developed after injections with hepatocyte growth factor (HGF) oligonucleotides, which was rejected by surviving syngeneic spleen graftTadako Nakatsuji
Leukemia & Lymphoma|April 15, 2003
Natural killer cell lymphoma in the duodenumMasahiko Sumi, Tetsuzo Tauchi, Goro Sashida, et al.
Leukemia & Lymphoma|April 15, 2003
Primary ALK positive anaplastic large cell lymphoma of the pancreasYossi Cohen, Diana Libster, Gail Amir, et al.
Leukemia & Lymphoma|November 22, 2021
Angiogenic factors could help us to define patients obtaining complete response with undetectable minimal residual disease in untreated CLL patients treated by FCR: results from the CLL2010FMP, a FILO studyAnne Laure Gagez, Franciane Paul, Elina Alaterre, et al.
Leukemia & Lymphoma|November 25, 2021
Targeting acute myeloid leukemia through multimodal immunotherapeutic approachesAmanda C Przespolewski, Scott Portwood, Eunice S Wang
Leukemia & Lymphoma|March 16, 2021
Long-term follow-up of late chronic phase chronic myeloid leukemia patients treated with imatinib after interferon failure: a single center experienceSara Pepe, Emilia Scalzulli, Gioia Colafigli, et al.
Leukemia & Lymphoma|March 18, 2021
Penicillium genus as a source for anti-leukemia compounds: an overview from 1984 to 2020Ana Calheiros de Carvalho, Claudio Yoshio Ogawa, Luiza De Camillis Rodrigues, et al.
Leukemia & Lymphoma|November 17, 2021
Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experienceTerry K Pak, Brianne N Dixon, Michael J Buege, et al.
Pageof 998